In late March, regulators in Massachusetts launched an investigation into whether national marijuana companies had flouted state laws that limit the number of licenses that can be controlled by any one firm. The probe followed an investigation by the Boston Globe, which found that rivals Sea Hunter Therapeutics and Acreage Holdings had bragged to investors about amassing more marijuana licenses than the three allowed by the state.